TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight
Lydia Tabernero Mel Spigelman Andrew Wilkinson Tb Alliance University Of Manchester Innovation Factory Tabrix Ltd
Source: miragenews.com